Arctigenin.

Arctiin is the glucoside of arctigenin, and gut bacterial beta-glucosidases remove the sugar to release the aglycone. That means arctiin is effectively a delivery form for arctigenin whose conversion depends on the person's microbiota. Burdock seed extracts contain both, and the declared ratio changes what actually reaches circulation.

The step that converts arctiin to arctigenin is carried out by bacterial glycosidases in the colon, so the composition of the microbiota shapes how much aglycone is produced. This is the same dependency documented for daidzein to equol and for other dietary glycosides. It is a plausible mechanistic pairing, not something measured with a defined probiotic strain and arctigenin together.

Several Lactobacillus plantarum strains express beta-glucosidase and are used industrially to deglycosylate plant glycosides during fermentation. Applied to a burdock seed preparation that logic would shift the arctiin to arctigenin balance before ingestion. The strain-level evidence is from fermentation work rather than from human dosing studies.

Burdock root is one of the richest food sources of inulin, so root preparations carry the fibre while seed preparations carry the lignans. Inulin feeds the bacterial populations that perform glycoside deglycosylation. The pairing is botanical happenstance with a coherent mechanistic rationale.

Arctigenin is a poorly water-soluble lignan, so dissolution rather than permeability tends to limit how much is absorbed. A medium-chain triglyceride vehicle keeps the compound in solution through the gut and recruits bile flow. The principle is standard for lipophilic plant actives and is not specific to arctigenin.

Complexing a poorly soluble polyphenol or lignan with phosphatidylcholine produces a phytosome, an approach used commercially to raise measured plasma levels of silymarin and curcumin. The same formulation logic applies to arctigenin. Whether it changes anything clinically for this specific molecule has not been shown.

Lecithin emulsifies lipophilic actives into fine droplets, increasing the surface area available for dissolution and micelle formation. It is the usual non-soy carrier in softgel and powder preparations of plant lignans. This is formulation chemistry, not an effect measured on arctigenin outcomes.

Piperine inhibits UDP-glucuronosyltransferase and some CYP enzymes, and glucuronidation is the main route by which dietary lignans are cleared. Adding piperine to a lignan preparation would be expected to slow that clearance. The same mechanism raises exposure to other co-administered compounds and medicines, which is the reason for caution rather than enthusiasm.

Curcumin and arctigenin are both poorly soluble polyphenolic compounds cleared largely by glucuronidation and sulfation. Given together they compete for the same conjugating enzymes, which can raise the exposure to either one unpredictably. Formulators pair them for overlapping mechanistic interests, but the kinetic interaction is the part that is actually established.

Quercetin is a substrate and an inhibitor of the same phase II enzymes that conjugate dietary lignans, so co-dosing shifts how quickly each is cleared. Direction and size of the shift depend on dose and on which enzyme dominates. Read it as a kinetic interaction rather than an added benefit.

EGCG is heavily glucuronidated and sulfated and interacts with intestinal efflux transporters, the same handling that applies to lignan aglycones. Combining concentrated polyphenol extracts stacks that competition. Both are commonly present in the same botanical blends, so the overlap is worth naming.

Resveratrol and arctigenin are both studied in cell systems for effects on energy sensing pathways including AMPK, and both are cleared rapidly by conjugation. The overlap in reported cell mechanisms is what drives their combination in blends. No human combination data exists for the pair.

Silymarin is a flavonolignan complex and arctigenin is a dibenzylbutyrolactone lignan, and both are poorly soluble compounds studied in liver cell models. They appear together in botanical blends built around that shared interest. The rationale is mechanistic and preclinical, not a measured combination result.

When a lipophilic lignan is delivered in an oil base, tocopherol protects the carrier oil from peroxidation over shelf life. That keeps the finished product chemically stable rather than changing what the active does. It is a formulation antioxidant role.